Chuang Gung Medical Foundation, Division of Pediatric Allergy, Asthma and Rheumatology - UNREGISTERED VERSION

Shi-Ting Tseng

Fellow of Department of Pediatric Allergy, Asthma and Rheumatology, Chang Gung Children’s Hospital

Teaching or Professional Positions:
Residency in Department of Pediatrics, Chang Gung Children’s Hospital

Professional Membership:
Member of Taiwan Pediatric Association

Specialty:
General pediatrics, Pediatric allergy, asthma and rheumatology

Research interest:
Clinical features and outcomes of lupus nephritis

Chao-Yi Wu  Ph.D.

Fellow of Department of Pediatric Allergy, Asthma and Rheumatology, Chang Gung Children’s Hospital

Teaching or Professional Positions:

Doctor of Philosophy (Ph.D.)2009-2013
Department of pathobiology School of medicine, Johns Hopkins University Baltimore, Maryland U.S.A.
Post-Doc Research Fellow (2008/5 ~ 2009/4)
Department of Pathology, Gynecologic Pathology, Johns Hopkins Medical Institute, Maryland, USA
Clinical Fellow training(2007/6 ~ 2007/12)
Department of Pediatrics, Immunology subspecialty, National Taiwan University Hospital, Taipei, Taiwan
Residency training (2004~2007)
Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan
Rotating Intern (2002 ~ 2004)
Chang Gung Memorial Hospital, Taoyuan, Taiwan

Professional Membership:
Member of Taiwan Pediatric Association

Specialty:
General pediatrics, Pediatric allergy, asthma and rheumatology

Research interest:
1. Infection control

 a.  Antimicrobial-Lock Therapy
 b.  Biofilms and drug resistant
 c.  Immune escape and host response
     to quorum sensing

2. Tumor immunology:

a.  Tumor vaccine development
b.  Tumor microenvironment  
   modification
c.  The immune modification
   effect of radiotherapy in the tumor
   micro-environment

Publications:
1. Wu CY, Lee PI. Antibiotic-Lock Therapy and erythromycin for treatment of catheter-related Candida parasilosis and Staphylococcus aureus infections. J Antimicrob Chemother Vol. 60 Issue 3 Pg. 706-7 (Sep 2007)

2.Tseng CW, Monie A, Wu CY, Huang B, Wang MC, Hung CF, Wu TC. Treatment with proteasome inhibitor bortezomib enhances antigen-specific CD8+ T-cell-mediated antitumor immunity induced by DNA vaccination.J Mol Med (Berl). 2008 Aug;86(8):899-908. Epub 2008 Jun 10.

3. Wu CY*, Tsen SW*, Meneshian A, Pai SI, Hung CF, Wu TC. Femtosecond laser treatment enhances DNA transfection efficiency in vivo. J Biomed Sci. 2009 Apr 1;16:36. ( *co-first author )

4. Mao CP, Hung CF, Kang TH, He L, Tsai YC, Wu CY, Wu TC. Combined administration with DNA encoding vesicular stomatitis virus G protein enhances DNA vaccine potency. J Virol. 2010 Mar;84(5):2331-9. Epub 2009 Dec 16.

5. Wu CY, Monie A, Pang X, Hung CF, Wu TC. Improving therapeutic HPV peptide-based vaccine potency by enhancing CD4+ T help and dendritic cell activation. J Biomed Sci. 2010 Nov 22;17:88.

6. Wu CY, Yang HY, Monie A, Ma B, Tsai HH, Wu TC, Hung CF. Intraperitoneal administration of poly(I:C) with polyethylenimine leads to significant antitumor immunity against murine ovarian tumors. Cancer Immunol Immunother. 2011 Aug;60(8):1085-96. Epub 2011 Apr 28.

7. Wu CY, Yang LH , Yang HY, Knoff J, Peng S, Hung CF and Wu TC. Targeted Delivery of Immunogenic Antigen to the Tumor Microenvironment After Irradiation Facilitates Tumor Control. 2013 Clin Cancer Res. (In press)

8. Yang HY, Barbi J, Wu CY, Zheng Y, Park B, Bandara S, Wu RC, Pardoll DM, Pan F. The MicroRNA miR-17 modulates regulatory T cell activity by targeting Foxp3 Co-regulators. 2013 (submitted)